OLMA
Olema Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -6.9% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -5 | 48.00M | $600.59M | +5 | −10 |
| Q1 2026 | 85 | +7 | 50.63M | $755.34M | +15 | −8 |
| Q4 2025 | 78 | +3 | 39.80M | $995.19M | +3 | n/a |
| Q3 2025 | 16 | 0 | 15.07M | $147.57M | +1 | −1 |
| Q2 2025 | 13 | -1 | 13.76M | $58.63M | n/a | −1 |
| Q1 2025 | 11 | -1 | 8.23M | $30.93M | +1 | −2 |
| Q4 2024 | 12 | 0 | 11.47M | $66.81M | n/a | n/a |
| Q3 2024 | 11 | 0 | 7.78M | $92.93M | +1 | −1 |
| Q2 2024 | 11 | n/a | 6.52M | $70.59M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 4.73M | +2.6% | $46.27M | 0.0% | ▲ Add | 2 | SEC ↗ ×10 |
| 2 | The Vanguard Group ✦ (pasif) | 3.20M | -2.1% | $31.30M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 3 | Morgan Stanley ✦ | 1.56M | n/a | $15.23M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 4 | Geode Capital Management ✦ (pasif) | 1.28M | -3.8% | $12.49M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 1.24M | -27.6% | $12.11M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (pasif) | 1.09M | +4.0% | $10.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 803.88K | n/a | $7.87M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 331.45K | -73.9% | $3.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 245.42K | Baru | $2.40M | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 204.21K | -10.4% | $2.00M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 11 | Two Sigma Investments ✦ | 109.53K | +18.4% | $1.07M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 90.10K | +53.2% | $882,079 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 81.18K | -2.0% | $794,761 | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
| 14 | JPMorgan Chase ✦ | 60.26K | n/a | $589,966 | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 15 | T. Rowe Price ✦ | 31.78K | +6.4% | $312,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 29.42K | +4.2% | $288,045 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $2.40M | 0.0% |
Telah keluar
| Marshall Wace | $54,528 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 200.00K saham, $10,000 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.